SG Americas Securities, LLC
Broker-DealerPosition in KRYS — Krystal Biotech, Inc.
CIK 1313360
NEW YORK, NY
Position in KRYS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,001,355
+$4,477,526 QoQ
Shares Held
16,147
+173.7% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#101
of 419 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. KRYS ranks #16 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in KRYS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,001,355 | 16,147 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,523,829 | 5,899 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $4,661,824 | 18,909 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $585,726 | 3,318 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,732,958 | 12,607 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $236,553 | 1,312 | Shares | Sole | 2025-04-15 | |
| 2024-09-30 | $459,989 | 2,527 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $139,933 | 762 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,246,755 | 7,007 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,340,391 | 18,865 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $2,428,924 | 20,939 | Shares | Sole | 2023-10-13 | |
| 2023-03-31 | $457,462 | 5,714 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $3,071,676 | 38,774 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $163,098 | 2,340 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $1,475,380 | 22,470 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,601,780 | 39,101 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $3,670,276 | 52,470 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,724,422 | 52,182 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $2,450,788 | 36,041 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,908,260 | 37,750 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,579,280 | 42,988 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $2,448,640 | 56,879 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $856,399 | 20,676 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||